Live Breaking News & Updates on Prnewswire Halozyme Therapeutics Inc

Stay updated with breaking news from Prnewswire halozyme therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Halozyme and Acumen Pharmaceuticals Enter Global Collaboration and Non-Exclusive License Agreement for the ENHANZE® Technology in Alzheimer's Disease

/PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced a global collaboration and non-exclusive license agreement with Acumen. ....

San Diego , United States , Eli Lilly , Helen Torley , Shannia Coley , Bristol Myers Squibb , Halozyme Therapeutics Inc , Acumen Pharmaceuticals , Idorsia Pharmaceuticals , Drug Administration , Prnewswire Halozyme Therapeutics Inc , Corporate Communications , Teva Pharmaceutical , World Health Organization , Exchange Commission , Health Organization , Fast Track , Horizon Therapeutics , Viiv Healthcare , Chugai Pharmaceutical , Quarterly Reports , Investor Relations , Halozyme Therapeutics ,

Halozyme To Report Third Quarter 2023 Financial and Operating Results

/PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its third quarter 2023 financial and operating results. ....

San Diego , United States , Eli Lilly , Teva Pharmaceuticals , Prnewswire Halozyme Therapeutics Inc , Halozyme Therapeutics Inc , Bristol Myers Squibb , Corporate Communications , Idorsia Pharmaceuticals , Horizon Therapeutics , Viiv Healthcare , Investor Relations , Halozyme Therapeutics , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Conference Call Announcements ,

Halozyme To Report Third Quarter 2023 Financial and Operating Results

SAN DIEGO, Oct. 30, 2023 /PRNewswire/ Halozyme Therapeutics, Inc. today announced it will release its third quarter 2023 financial and operating results on Monday, November 6, 2023, following. ....

San Diego , United States , Eli Lilly , Idorsia Pharmaceuticals , Bristol Myers Squibb , Prnewswire Halozyme Therapeutics Inc , Halozyme Therapeutics Inc , Teva Pharmaceuticals , Corporate Communications , Horizon Therapeutics , Viiv Healthcare , Investor Relations ,

Halozyme To Report Third Quarter 2023 Financial and Operating Results

Halozyme To Report Third Quarter 2023 Financial and Operating Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Eli Lilly , Idorsia Pharmaceuticals , Halozyme Therapeutics Inc , Teva Pharmaceuticals , Bristol Myers Squibb , Corporate Communications , Prnewswire Halozyme Therapeutics Inc , Horizon Therapeutics , Viiv Healthcare , Investor Relations ,

Positive Topline Results Reported from Bristol Myers Squibb's Phase 3 CheckMate-67T Trial of Subcutaneous Nivolumab with Halozyme's ENHANZE® Drug Delivery Technology for Advanced or Metastatic Clear Cell Renal Cell Carcinoma

BMS in discussions with health authorities regarding next steps for submission and approval of subcutaneous nivolumab in multiple indications
SAN DIEGO, Oct. 19, 2023 /PRNewswire/ Halozyme. ....

San Diego , United States , Bristol Myers Squibb , Eli Lilly , Exchange Commission , Prnewswire Halozyme Therapeutics Inc , Halozyme Therapeutics Inc , Teva Pharmaceutical , Corporate Communications , Idorsia Pharmaceuticals , Blinded Independent Central Review , Halozyme Therapeutics , Horizon Therapeutics , Viiv Healthcare , Annual Report , Quarterly Reports , Investor Relations ,